Article
Immunohistochemistry for EGFR Mutation Detection in Non-Small-Cell Lung Cancer.
Clinical lung cancer - 1 May 2017
Hitij Nina Turnšek, Kern Izidor, Sadikov Aleksander, Knez Lea, Stanič Karmen, Zwitter Matjaž, Cufer Tanja
Abstract excerpt
INTRODUCTION: The sensitivity and specificity of immunohistochemistry (IHC) was compared with the standard polymerase chain reaction (PCR)-based method for detecting common activating epidermal growth factor receptor (EGFR) mutations in non-small-cell lung cancer (NSCLC). Additionally, we evaluated predictive value of IHC EGFR mutation-positive status for EGFR tyrosine kinase inhibitor (TKI) treatment outcome and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
